D E Levy
Overview
Explore the profile of D E Levy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
6453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng J, Levy D, McCurley J, Rimm E, Gelsomin E, Thorndike A
Prev Med Rep
. 2024 May;
42:102736.
PMID: 38699077
Objective: Whether employees' health status is associated with the effectiveness of workplace health promotion programs is unknown. The objective of this study was to determine if the effect of a...
2.
Arku R, Adamkiewicz G, Vallarino J, Spengler J, Levy D
Indoor Air
. 2014 Apr;
25(1):13-20.
PMID: 24750252
The risk of tobacco smoking and second-hand smoke (SHS) exposure combined are the leading contributors to disease burden in high-income countries. Recent studies and policies are focusing on reducing exposure...
3.
Poe S, Arora M, Oriss T, Yarlagadda M, Isse K, Khare A, et al.
Mucosal Immunol
. 2012 Jul;
6(1):189-99.
PMID: 22785228
Bacterial pneumonia remains a significant burden worldwide. Although an inflammatory response in the lung is required to fight the causative agent, persistent tissue-resident neutrophils in non-resolving pneumonia can induce collateral...
4.
Lal G, Yin N, Xu J, Lin M, Schroppel S, Ding Y, et al.
Am J Transplant
. 2011 Jan;
11(2):203-14.
PMID: 21219575
Foxp3 expression in regulatory T cells (Treg) is required for their development and suppressive function. How different inflammatory signals affect Foxp3 chromatin structure, expression and Tregs plasticity are not completely...
5.
Tseng J, Zheng Y, Yee H, Levy D, Meruelo D
Gene Ther
. 2007 May;
14(15):1166-74.
PMID: 17508007
Our previous studies suggest that replication-defective Sindbis vectors might be promising agents for specific tumor targeting and detection. However, the effects of innate and/or adaptive anti-viral immunity, in particular, the...
6.
Marsh R, Rocha Lima C, Levy D, Mitchell E, Rowland Jr K, Benson 3rd A
Am J Clin Oncol
. 2007 Feb;
30(1):26-31.
PMID: 17278891
Background: Perifosine, a heterocyclic alkylphosphocholine signal transduction inhibitor, has activity against multiple cell types in vitro. This is a phase II study to determine activity and toxicity of perifosine in...
7.
Giantonio B, Levy D, ODwyer P, Meropol N, Catalano P, Benson 3rd A
Ann Oncol
. 2006 Jul;
17(9):1399-403.
PMID: 16873427
Aim: Patients with untreated advanced colorectal cancer were enrolled to this single arm phase II multi-center cooperative group trial of bevacizumab combined with IFL. The first 20 patients received irinotecan...
8.
Vitale M, Levy D, Moskowitz A, Gelijns A, Spellmann M, Verdisco L, et al.
J Pediatr Orthop
. 2001 Aug;
21(5):629-35.
PMID: 11521032
There is a clear need for standardized measures to assess health status that are valid and appropriate to the needs of children with orthopaedic problems. The Child Health Questionnaire and...
9.
Vitale M, Levy D, Johnson M, Gelijns A, Moskowitz A, Roye B, et al.
J Pediatr Orthop
. 2001 Aug;
21(5):622-8.
PMID: 11521031
New pressures of accountability brought on by a rapidly evolving system of health care financing have underscored the need for standardized, valid measures of patient outcome that reflect the effect...
10.
Polyak S, Khabar K, Paschal D, Ezelle H, Duverlie G, Barber G, et al.
J Virol
. 2001 Jun;
75(13):6095-106.
PMID: 11390611
Hepatitis C virus (HCV), a major cause of liver disease worldwide, is frequently resistant to the antiviral alpha interferon (IFN). The HCV nonstructural 5A (NS5A) protein has been implicated in...